-
The BIR issued Revenue Memorandum Circular 62-2025, adding 10 more VAT-exempt medicines for cancer, diabetes, high cholesterol, hypertension, and mental illness, reducing healthcare costs for Filipino patients.
-
The VAT exemption aligns with RA 10963 (TRAIN Law) and RA 11534 (CREATE Act), reflecting a government push to improve access to essential medicines through updated tax relief measures.
-
Newly exempt medicines include tegafur-based oral chemotherapy, metformin-teneligliptin for diabetes, atorvastatin-fenofibrate for cholesterol, metoprolol-ivabradine for hypertension, and lamotrigine in various formulations for mental health treatment.
-
The BIR emphasized continued collaboration with the FDA and DOH, pledging further reviews to expand the VAT-free medicine list and enhance public health support through tax policy.
Sources:
Latest Posts in "Philippines"
- Philippine Court Voids VAT Assessment for Lack of Annexes, Upholds Zero-Rating for Freeport Sales
- BOC Assigns Procedural Code 062 for VAT on Local Sales to Domestic Market Enterprises
- BIR Takes Over VAT Oversight on Local Sales from Bureau of Customs
- Supreme Court Ruling Clarifies VAT Zero-Rating for Freeport and Ecozone Enterprises in the Philippines
- Philippines Considers VAT Cut, Fiscal Incentives to Boost Garment Industry Competitiveness
